• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

COVID-19 vaccines and Multiple sclerosis – update

February 26, 2021  

COVID-19 vaccines and Multiple sclerosis

February 11, 2021  

Novel anti-CD20 monoclonal approved in Canada for MS

January 27, 2021  

COVID vaccine guidance for MS patients

January 22, 2021  

Multiple sclerosis 2021 – a look ahead

January 13, 2021  

This just in – Winners of the 2020 Awards in Multiple Sclerosis

December 16, 2020  

McDonald 2017 update – more research required

December 9, 2020  

The Year in Review – virtual EBM and SPMS

December 2, 2020  

Ozanimod vs. fingolimod: is there a difference?

November 13, 2020  

B cell-directed therapies in MS – POST-ECTRIMS SPECIAL REPORT

October 23, 2020  
Previous
17
18
19
20
21
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
  • High-efficacy DMTs for MS: the year in review posted on December 1, 2025
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions